ARVINAS, INC.
ARVNCIK 0001655759 · Pharmaceutical Preparations · Nasdaq
- ARVINAS INC. (until 2018-10-10)
- ARVINAS HOLDING COMPANY, LLC (until 2018-09-28)
Revenue (TTM)
$216.1M
+114.2% YoY
Q1 May 2026
Net Income (TTM)
−$71M
+59.4% YoY
Q1 May 2026
EPS Diluted (TTM)
−$1.08
+58.8% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-49.8%
Q1 May 2026
Net Margin
-32.9%
Q1 May 2026
Free Cash Flow (TTM)
−$349.7M
Q1 May 2026
Cash
$87.3M
Q1 May 2026
Total Debt
$500K
Q1 May 2026
Shares Outstanding
64.52M sh
Q1 May 2026